Temonat (temozolomide) for Injection

Temonat is a brand-name prescription drug that’s FDA-approved to treat brain tumors such as glioblastoma and anaplastic astrocytoma. Temonat (temozolomide) for Injection administered via intravenous infusion Initial U.S. Approval: 1999

Home | (temozolomide) for Injection

Temonat (temozolomide) for Injection Price In India and Overseas
TEMONAT (temozolomide) for Injection

Submit a request to access drug used to treat, diagnose or prevent serious or life-threatening conditions.We’ll get back to you within 1 business days!

For Overseas Patient/ Export inquires.

Call / WhatsApp Number
+91 9643240915 (Mr. Yashpal Singh)
+91 9289711087 (Ms. Sana Sadyar)

For any urgent inquiries or assistance needed, please reach out to our Support Team. Rest assured, we will respond within 24 hours, from Monday to Saturday, during the hours of 9:00 A.M to 18:00 PM.

TEMONAT (temozolomide) for Injection

Temozolomide is approved to treat the following types of brain tumors in adults:Anaplastic astrocytoma, Glioblastoma multiforme (GBM).

Temonat 100mg 5 Capsule belongs to a class of medicines called ‘anti-cancer/ antitumor agent’, used to treat specific forms of brain tumours such as glioblastoma multiforme (a type of tumour that grows and spreads rapidly) in adults and malignant glioma, including glioblastoma multiforme or anaplastic astrocytoma (a rare malignant brain tumour) in patients older than 3years. Temonat 100mg 5 Capsule contains Temozolomide which works by inhibiting the production of DNA (deoxyribonucleic acid-genetic material of the cell), thereby affecting cell growth and division. Thus, Temonat 100mg 5 Capsule prevents tumours from growing.

Temozolomide, A drug used to treat adults with certain types of brain tumors. It is also being studied in the treatment of other types of cancer. Temozolomide damages the cell’s DNA and may kill cancer cells. It is a type of alkylating agent. Also called Temodar.
In the United States temozolomide is indicated for the treatment of adults with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and subsequently as monotherapy treatment; or adults with refractory anaplastic astrocytoma who have experienced disease progression on a drug regimen containing nitrosourea and procarbazine.
In the European Union temozolomide is indicated for adults with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and subsequently as monotherapy treatment; or children from the age of three years, adolescents and adults with malignant glioma, such as glioblastoma multiforme or anaplastic astrocytoma, showing recurrence or progression after standard therapy.

Drug (Brand / Generic): Temonat / temozolomide for Injection
Current Indications: brain tumors
Approval Date: 2015

Available as (Form & Strength): 5-mg, 20-mg, 100-mg, 140-mg, 180-mg, and 250-mg capsules

For more highlights of prescribing information regarding Indications and usage, dosage and administration, dosage forms and strengths, patient counseling information and medication guide. Click Here

Alleviare Life Sciences

About Us

Alleviare Life Sciences Pvt. Ltd. (India) serves as a facilitator for medical and pharmaceutical products, commencing its operations in 2005. Headquartered in Delhi, India, Alleviare operates nationwide, providing a range of comprehensive services to patients, doctors, hospitals, and government healthcare facilities.

Our specialization lies in facilitating access to medicines, leveraging our expertise in sourcing and providing documentation assistance for programs such as Named Patient Program, Managed Access Program, and Early Access Program. We take pride in ensuring smooth and efficient access to medications for those who require them.

Alleviare India, a certified pharmaceutical facilitator / supplier / importer of specialty medicines or drugs based in India.